Next Article in Journal
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Previous Article in Journal
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain
 
 
Article

Article Versions Notes

Cancers 2024, 16(13), 2302; https://doi.org/10.3390/cancers16132302
Action Date Notes Link
article xml file uploaded 22 June 2024 12:03 CEST Original file -
article xml uploaded. 22 June 2024 12:03 CEST Update https://www.mdpi.com/2072-6694/16/13/2302/xml
article pdf uploaded. 22 June 2024 12:03 CEST Version of Record https://www.mdpi.com/2072-6694/16/13/2302/pdf
article supplementary file uploaded. 22 June 2024 12:03 CEST - https://www.mdpi.com/2072-6694/16/13/2302#supplementary
article html file updated 22 June 2024 12:05 CEST Original file https://www.mdpi.com/2072-6694/16/13/2302/html
Back to TopTop